Suppr超能文献

用于治疗骨关节炎的透明质酸结合肽-聚合物系统。

A hyaluronic acid binding peptide-polymer system for treating osteoarthritis.

机构信息

Translational Tissue Engineering Center, Wilmer Eye Institute and Department of Biomedical Engineering, Johns Hopkins University, Baltimore, MD, 21287, USA.

Information Sciences Institute, University of Southern California, Arlington, VA 22203, USA.

出版信息

Biomaterials. 2018 Nov;183:93-101. doi: 10.1016/j.biomaterials.2018.08.045. Epub 2018 Aug 21.

Abstract

Hyaluronic acid (HA) is found naturally in synovial fluid and is utilized therapeutically to treat osteoarthritis (OA). Here, we employed a peptide-polymer cartilage coating platform to localize HA to the cartilage surface for the purpose of treating post traumatic osteoarthritis. The objective of this study was to increase efficacy of the peptide-polymer platform in reducing OA progression in a mouse model of post-traumatic OA without exogenous HA supplementation. The peptide-polymer is composed of an HA-binding peptide (HABP) conjugated to a heterobifunctional poly (ethylene glycol) (PEG) chain and a collagen binding peptide (COLBP). We created a library of different peptide-polymers and characterized their HA binding properties in vitro using quartz crystal microbalance (QCM-D) and isothermal calorimetry (ITC). The peptide polymers were further tested in vivo in an anterior cruciate ligament transection (ACLT) murine model of post traumatic OA. The peptide-polymer with the highest affinity to HA as tested by QCM-D (∼4-fold greater binding compared to other peptides tested) and by ITC (∼3.8-fold) was HABP2-8-arm PEG-COLBP. Biotin tagging demonstrated that HABP2-8-arm PEG-COLBP localizes to both cartilage defects and synovium. In vivo, HABP2-8-arm PEG-COLBP treatment and the clinical HA comparator Orthovisc lowered levels of inflammatory genes including IL-6, IL-1B, and MMP13 compared to saline treated animals and increased aggrecan expression in young mice. HABP2-8-arm PEG-COLBP and Orthovisc also reduced pain as measured by incapacitance and hotplate testing. Cartilage degeneration as measured by OARSI scoring was also reduced by HABP2-8-arm PEG-COLBP and Orthovisc. In aged mice, HABP2-8-arm PEG-COLBP therapeutic efficacy was similar to its efficacy in young mice, but Orthovisc was less efficacious and did not significantly improve OARSI scoring. These results demonstrate that HABP2-8-arm PEG-COLBP is effective at reducing PTOA progression.

摘要

透明质酸(HA)存在于滑液中,可用于治疗骨关节炎(OA)。在这里,我们采用肽-聚合物软骨涂层平台将 HA 定位到软骨表面,用于治疗创伤后骨关节炎。本研究的目的是提高肽-聚合物平台在减少创伤后 OA 小鼠模型中 OA 进展的疗效,而无需外源性 HA 补充。该肽-聚合物由与异双功能聚乙二醇(PEG)链和胶原结合肽(COLBP)偶联的 HA 结合肽(HABP)组成。我们创建了不同肽-聚合物的文库,并使用石英晶体微天平(QCM-D)和等温量热法(ITC)在体外表征其 HA 结合特性。肽聚合物进一步在创伤后 ACL 切断(ACLT)的小鼠模型中进行了体内测试。通过 QCM-D(与其他测试的肽相比,结合增加约 4 倍)和 ITC(增加约 3.8 倍)测试,对 HA 具有最高亲和力的肽聚合物为 HABP2-8-臂 PEG-COLBP。生物素标记表明 HABP2-8-臂 PEG-COLBP 定位于软骨缺陷和滑膜。在体内,HABP2-8-臂 PEG-COLBP 治疗和临床 HA 对照物 Orthovisc 降低了包括 IL-6、IL-1B 和 MMP13 在内的炎症基因的水平,与盐水处理的动物相比,增加了年轻小鼠的聚集蛋白表达。HABP2-8-臂 PEG-COLBP 和 Orthovisc 还通过 incapacitance 和热板测试降低了疼痛。通过 OARSI 评分测量的软骨退化也被 HABP2-8-臂 PEG-COLBP 和 Orthovisc 降低。在老年小鼠中,HABP2-8-臂 PEG-COLBP 的治疗效果与其在年轻小鼠中的效果相似,但 Orthovisc 的效果较差,并且 OARSI 评分没有显著改善。这些结果表明 HABP2-8-臂 PEG-COLBP 可有效减轻 PTOA 的进展。

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验